Corrigendum: Integrative analysis of COL6A3 in lupus nephritis: insights from single-cell transcriptomics and proteomics

Corrigendum: Integrative analysis of COL6A3 in lupus nephritis: insights from single-cell transcriptomics and proteomics

Saved in:

Bibliographic Details
Main Authors:	Lisha Mou, Fan Zhang, Xingjiao Liu, Ying Lu, Mengli Yue, Yupeng Lai, Zuhui Pu, Xiaoyan Huang, Meiying Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-10-01
Series:	Frontiers in Immunology
Subjects:	systemic lupus erythematosus kidney disease lupus nephritis single-cell RNA sequencing proteomics COL6A3
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1508292/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MicroRNA-203 Expression as Potential Biomarker for Lupus Nephritis [Corrigendum]
by: Setyawan Y, et al.
Published: (2025-04-01)

Lupus nephritis – modern aspects of diagnosis and therapy. Part I
by: S. K. Solovyev, et al.
Published: (2024-03-01)

Clinical significance of urine hepcidin in lupus nephritis
by: TANG Dai-rong, et al.
Published: (2017-01-01)

Lupus nephritis. Part II, modern ideas about therapy
by: Elena A. Aseeva, et al.
Published: (2024-09-01)

A Rare Case of Lupus Nephritis with Predominant Gastrointestinal Manifestation: A Case Study
by: Jasmine Podimon, et al.
Published: (2024-12-01)

Risk factors for infections in patients with lupus nephritis and construction of a prediction model
by: Liu Ding-lin, et al.
Published: (2025-04-01)

Risk factors for infections in patients with lupus nephritis and construction of a prediction model
by: Liu Ding-lin, et al.
Published: (2025-04-01)

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

Programmed immunoadsorption with regeneration of adsoption columns in the treatment of lupus nephritis
by: A. A. Sokolov, et al.
Published: (2020-09-01)

Comparison of Pregnancy Outcomes between Lupus Nephritis Patients and Nonlupus Nephritis Systemic Lupus Erythematosus Patients at a Tertiary Care Center in Mumbai
by: Preeti Mehta Nagnur, et al.
Published: (2025-01-01)

Role of urinary biomarkers in the prognostic assessment of lupus nephritis
by: HUANG Biyao, LI Wengen
Published: (2025-04-01)

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part I
by: N. L. Kozlovskaya, et al.
Published: (2020-11-01)

Determination of nutrition index and correlation with activity of lupus nephritis
by: Rabrenović Violeta, et al.
Published: (2024-01-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

Potential of serum sulfatide levels as a marker for classification and disease activity in lupus nephritis
by: Kosuke Yamaka, et al.
Published: (2025-06-01)

Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis
by: Han Zhang, et al.
Published: (2023-12-01)

Severe lupus nephritis with nephrotic syndrome after a treatment of belimumab: one case report
by: Gao Yue-ming, et al.
Published: (2021-01-01)

Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents
by: Anca D. Askanase, et al.
Published: (2025-04-01)

Clinicopathological Features of Lupus Nephritis Patients in North-East India; A Single Center Retrospective Observational Study
by: Shahzad Alam, et al.
Published: (2021-12-01)

Clinical value of antineutrophil cytoplasmic antibody positive expression in children with lupus nephritis
by: Jing Wang, et al.
Published: (2024-11-01)

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01)

Outcome of proliferative lupus nephritis with thrombotic microangiopathy; An ambispective observational single-center study
by: Ahmed Fayed, et al.
Published: (2025-05-01)

Triglyceride-glucose index is associated with lupus nephritis and gender disparity in systemic lupus erythematosus patients
by: Shuhan Lin, et al.
Published: (2025-05-01)

Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis
by: Ioannis Parodis, et al.
Published: (2024-06-01)

Clinical and morphological correlations in patients with lupus nephritis: a retrospective study
by: Kseniia V. Kurginian, et al.
Published: (2024-01-01)

The Complex Role of Gut Microbiota in Systemic Lupus Erythematosus and Lupus Nephritis: From Pathogenetic Factor to Therapeutic Target
by: Emanuele Parodi, et al.
Published: (2025-02-01)

Successful Management Strategies for Lupus Nephritis in the Intensive Care Unit: A Case Series
by: Achmad Marwan, et al.
Published: (2025-01-01)

Analysis of the Sensitivity and Specificity of Histopathological Findings for Diagnosing Lupus Nephritis
by: Epitácio Rafael da Luz Neto, et al.
Published: (2024-11-01)

<i>FCGR2A</i>-131R Is Associated with Lupus Nephritis Rather than Non-Lupus Nephritis SLE in an Indigenous African Caribbean Population
by: Fatima Radouani, et al.
Published: (2025-06-01)

Correlation between dyslipidemia and disease activity of lupus nephritis
by: Hu Hong-tu, et al.
Published: (2021-01-01)

The role of repeat kidney biopsy in patients with lupus nephritis (case report)
by: N. Yu. Nikishin, et al.
Published: (2024-04-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Diagnostic model of microvasculature and neurologic alterations in the retina and optic disc for lupus nephritis
by: Yun Yu, et al.
Published: (2024-12-01)

Identification of new hub- ferroptosis-related genes in Lupus Nephritis
by: Xiao-Jie Zheng, et al.
Published: (2024-12-01)

Therapeutically targeting proinflammatory type I interferons in systemic lupus erythematosus: efficacy and insufficiency with a specific focus on lupus nephritis
by: Benjamin Lai, et al.
Published: (2024-10-01)

Research advances of the role of T lymphocytes in lupus nephritis
by: Zhang Ling-ge, et al.
Published: (2022-03-01)

Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus
by: N. Yu. Nikishina, et al.
Published: (2025-06-01)

Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients
by: Xin-ran Liu, et al.
Published: (2023-12-01)

Mediterranean fever gene variants may prevent the development of lupus nephritis in Japanese patients with systemic lupus erythematosus
by: Yushiro Endo, et al.
Published: (2025-07-01)

Identification of amino acids metabolomic profiling in human plasma distinguishes lupus nephritis from systemic lupus erythematosus
by: Zui-Shuang Guo, et al.
Published: (2024-09-01)